Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphocytic Leukemia (ALL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00038883
What this trial is testing

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

Who this might be right for
Leukemia, Lymphocytic, ChronicLeukemia, Lymphocytic, AcuteLymphoma, Low-Grade+2 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00001637
What this trial is testing

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 28
Not applicableStudy completedNCT06578351
What this trial is testing

TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)

Who this might be right for
Atopic DermatitisPediatric ALL
Danone Asia Pacific Holdings Pte, Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00053131
What this trial is testing

Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Testing effectiveness (Phase 2)Study completedNCT02588651
What this trial is testing

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

Who this might be right for
T-cell LymphomaAngioimmunoblastic T-cell LymphomaHepato-splenic T-cell Lymphoma+3 more
Deepa Jagadeesh 23
Testing effectiveness (Phase 2)WithdrawnNCT05895201
What this trial is testing

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Who this might be right for
Bone Marrow Transplant ComplicationsAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia, Adult+2 more
Indiana University
Testing effectiveness (Phase 2)Study completedNCT00003305
What this trial is testing

Aminopterin in Treating Patients With Refractory Leukemia

Who this might be right for
Leukemia
Genzyme, a Sanofi Company 75
Testing effectiveness (Phase 2)UnknownNCT02776605
What this trial is testing

Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia

Who this might be right for
ALL
PETHEMA Foundation 30
Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Very early researchNot Yet RecruitingNCT07256353
What this trial is testing

Allogeneic UCB-derived CAR-T for B-ALL

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
The General Hospital of Western Theater Command 50
Not applicableEnded earlyNCT02580981
What this trial is testing

Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses

Who this might be right for
Leukemia, Acute Lymphoblastic
New Mexico Cancer Research Alliance 21
Early research (Phase 1)Looking for participantsNCT07257419
What this trial is testing

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

Who this might be right for
Relapsed Pediatric ALLHematopoietic Cell TransplantationHematologic Malignancy
St. Jude Children's Research Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06918431
What this trial is testing

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma
City of Hope Medical Center 53
Not applicableStudy completedNCT00899366
What this trial is testing

DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
ECOG-ACRIN Cancer Research Group 49
Early research (Phase 1)Study completedNCT00003005
What this trial is testing

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Boston Medical Center 14
Not applicableStudy completedNCT02767388
What this trial is testing

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

Who this might be right for
Myelodysplastic SyndromeEffects of ChemotherapyMild Cognitive Impairment+6 more
University of Nebraska 45
Testing effectiveness (Phase 2)Looking for participantsNCT05940961
What this trial is testing

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Who this might be right for
ALLMRD-positiveHematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD 42
Large-scale testing (Phase 3)UnknownNCT00003423
What this trial is testing

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
United Kingdom Children's Cancer Study Group 100
Next Page